Sponsored research
Geoffrey S. Ginsburg of Cardiology has received an award (W911NF-15-1-0161) from the Defense Advanced Research Projects Agency for a project entitled "Baseline Bio-molecular Models to Predict Infectious Disease Susceptibility." Total funding will be $1,135,823.
Joseph G. Rogers of Cardiology has received a sub-award (1R01-HL122639-01A1) through Carnegie Mellon University for a project entitled "Cardiac Outcomes Risk Assessment (CORA)." Total funding will be $71,479.
Gillian D. Schmidler of Cardiology has received an award from the Patient-Centered Outcomes Research Institute for a project entitled "Topic Refinement 2015." Total funding will be $50,624.
Deepak Voora of Cardiology has received an award (3R01-HL118049-03S1) from the National Institutes of Health for a project entitled "Gender Differences in the Platelet RNA response to Aspirin." Total funding will be $99,997.
Lisheng Zhang of Cardiology has received an award from the American Heart Association for a project entitled "Molecular Mechanisms by which Chronic Kidney Disease Potentiates Vein Graft Disease." Total funding will be $154,000.
Mark N. Feinglos of Endocrinology, Metabolism, and Nutrition has received a sub-award (HHSN268200900048C) through the Wake Forest University School of Medicine for a project entitled "Prevention of cardiovascular disease in diabetes mellitus-clinical center network sites." Total funding will be $206,816.
Harvey Jay Cohen of Geriatrics has received an award (3T32- AG000029-38S1) from the National Institutes of Health for a project entitled "T32 Bridge Funding." Total funding will be $115,582.
Mitchell E. Horwitz of Hematological Malignancies and Cellular Therapy has received a sub-award (5U10-HL69294-14) through the National Marrow Donor Program for a project entitled "A Randomized Multi-Center Phase III Trial of Calcineurin Inhibitor-Free Interventions for Prevention of Graft-Versus-Host Disease, BMT CTN Protocol #1301."
Nirmish R. Shah of Hematology has received an award (1R21-HS023989-01) from the Agency for Healthcare Research and Quality for a project entitled "Use of Mobile Technology to Improve Acute Care Utilization in Sickle Cell Disease." Total funding will be $299,999.
John A. Bartlett of Infectious Diseases has received an award (2P30-AI064518-11) from the National Institutes of Health for a project entitled "Clinical Core."
Mehri McKellar of Infectious Diseases has received an award (2P30-AI064518-11) from the National Institutes of Health for a project entitled "HIV and Aging SWG."
Susanna Naggie of Infectious Diseases has received an award (HHSN272201300017I-TO8-Option 2) from the National Institutes of Health for a project entitled "VTEU: Task Area C: Protocol Implementation - Option 2 Protocol #14-0053." Total funding will be $4,049,893.
Susanna Naggie of Infectious Diseases has received an award (HHSN272201300017I-TO8-Option 4) from the National Institutes of Health for a project entitled "VTEU: Task Area D: Research Laboratory Analysis Protocol #14-0053." Total funding will be $798,412.
Susanna Naggie of Infectious Diseases has received an award (HHSN272201300017I-TO8-Option 1) from the National Institutes of Health for a project entitled "VTEU: Option 1-Task Area B: Protocol Development Protocol #14-0053." Total funding will be $67,837.
Susanna Naggie of Infectious Diseases has received an award (HHSN272201300017I-TO8 -Base) from the National Institutes of Health for a project entitled "VTEU: Base -Task Area A: Project Logistics and Site Activation Protocol #14-0053." Total funding will be $141,485.
Gerard C. Blobe of Medical Oncology has received an award from the Alex's Lemonade Stand for a project entitled "Synergistic Differentiation Therapy in Neuroblastoma." Total funding will be $250,000.
Brent A. Hanks of Medical Oncology has received an award from the Fred Hutchinson Cancer Research Center for a project entitled "CITN-07 A Phase II, Open-label, Multicenter, Randomized Study of CDX-1401, a Dendritic Cell Targeting NY-ESO-1 Vaccine, in Patients with Malignant Melanoma Pre-Treated with Recombinant CDX-301, a Recombinant Human Flt3 Ligand." Total funding will be $20,000.
Victoria L. Seewaldt of Medical Oncology has received an award (3R01-CA158668-04S1) from the National Institutes of Health for a project entitled "Targeted Chemoprevention of Br Ca: From Bench to Clinical Testing Minority Suppl." Total funding will be $103,153.
Victoria L. Seewaldt of Medical Oncology has received a sub-award (R01-CA192914-) through the University of California - San Francisco for a project entitled "Tension-Stat3-miR-mediated metastasis." Total funding will be $228,043.
Robert F. Spurney of Nephrology has received an award from the Juvenile Diabetes Research Foundation for a project entitled "Targeting TRPC6 to Treat Diabetic Kidney Disease." Total funding will be $109,949.
Kevin A. Schulman of Medicine has received an award (PO #IP123304) from the Food and Drug Administration for a project entitled "FDA Fellow's Course 2015." Total funding will be $40,000.
Virginia B. Kraus of Rheumatology and Immunology has received an award from the National University of Singapore for a project entitled "A Randomized Controlled Trial of Colchicine for Symptom and Inflammation Modification in Knee Osteoarthritis." Total funding will be $110,231.
Industry-sponsored clinical trials
Brett D. Atwater of Cardiology has received an award from St. Jude Medical Inc. for a project entitled "STAR-VT." Total funding will be $205,530.
Gary M. Felker of Cardiology has received an award from Roche Diagnostics for a project entitled "HF ACTION." Total funding will be $511,004.
Camille G. Frazier-Mills of Cardiology has received an award from Medtronic, Inc. for a project entitled "Product Surveillance Registry (PSR)." Total funding will be $46,940.
Pierluigi Tricoci of Cardiology has received an award from CSL Behring LLC for a project entitled "A Phase 2b, Multi-center, Randomized, Placebo-controlled, Dose-ranging Study to Investigate the Safety and Tolerability of Multiple Dose Administration of CSL112 in Subjects with Acute Myocardial Infarction." Total funding will be $509,091.
Manal F. Abdelmalek of Gastroenterology has received an award from the Bristol-Myers Squibb Company for a project entitled “A Randomized, double-blind, placebo-controlled, parallel group, multiple dose study to evaluate the safety, pharmacokinetics and pharmacodynamics effects of BMS-986063 in Adults with Non-Alcoholic Steatohepatitis.” The total funding is $158,346.
Manal F. Abdelmalek of Gastroenterology has received an award from NGM Biopharmaceuticals for a project entitled "A Phase 2, Randomized, Double Blind, Placebo Controlled, Parallel Group, Multiple Center Study to Evaluate the Safety, Tolerability, and Efficacy of NGM282 Administered for 12 Weeks in Patients with Histologically Confirmed Nonalcoholic Steatohepatitis (NASH)." Total funding will be $239,646.
Andrew J. Muir of Gastroenterology has received an award from Merck Sharp & Dohme for a project entitled "MK-3682 PN011 A Phase II, Randomized, Open-Label Clinical Trial to Study the Efficacy and Safety of the Combination Regime of MK-5172 with Either MK-8742 or MK-8408 in Subjects with Chronic HCV GT1, GT2 and GT4 Infection "C-CREST 1." Total funding will be $115,195.
Nelson J. Chao of Hematological Malignancies and Cellular Therapy has received an award from Cantex Pharmaceuticals, Inc. for a project entitled "2-O, 3-O desulfated heparin for the prevention of GVHD." Total funding will be $76,320.
David Rizzieri of Hematological Malignancies and Cellular Therapy has received an award from KaloBios Pharmaceuticals, Inc for a project entitled "Study of the Anti-EphA3 Monoclonal Antibody KB004 in subjects with EphA3-Expressing Hematologic Malignancies." Total funding will be $152,770.
Thomas L. Ortel of Hematology has received an award from Discovery Life Sciences, Inc. for a project entitled "A Whole Blood Collection from subjects clinicially diagnosed with PNH." Total funding will be $21,758.
Thomas L. Ortel of Hematology has received an award from Siemens Healthcare Diagnostics for a project entitled "Siemens CS-2100i and CS-5100 New Generation Analyzers." Total funding will be $78,459.
Mehri McKellar of Infectious Diseases has received an award from Bristol-Myers/Sanofi Pharmaceuticals, Inc. Partnership for a project entitled "A Multi-arm Phase 3 Randomized Placebo Controlled Double Blind Clnical Trial to Investigate the Efficacy and Safety of BMS-663068 in Heavily Treatment Experienced Subjects Infected with Multi-drug Resistant HIV-1." Total funding will be $50,478.
Jeffrey Crawford of Medical Oncology has received an award from Fibrogen, Inc. for a project entitled "FibroGen, Inc. FGCL-3019-073, Phase 2, a Trial of FG 3019 Monotherapy as Neoadjuvant Treatment in Subjects with Stage I-II Squamous Non-Small Cell Lung Cancer." Total funding will be $94,976.
Shelby Reed of Other Medicine has received an award from Genzyme Corporation for a project entitled "High-Efficacy Treatments for Relapsing-Remitting MS pts." Total funding will be $285,271.
Shelby Reed of Other Medicine has received an award from Janssen Research & Development, LLC for a project entitled "Preference Studies in Alzheimer's Disease: General Population Surveys." Total funding will be $254,600.
Alice L. Gray of Pulmonary, Allergy, and Critical Care Medicine has received an award from PTC Therapeutics, Inc for a project entitled "PTC 124-GD-021-CF." Total funding will be $61,701.
Njira L. Lugogo of Pulmonary, Allergy, and Critical Care Medicine has received an award from GlaxoSmithKline for a project entitled "GSK Study 200862 Controled Asthma." Total funding will be $105,864.
Njira L. Lugogo of Pulmonary, Allergy, and Critical Care Medicine has received an award from GlaxoSmithKline for a project entitled "GSK 115733 COPD." Total funding will be $130,851.